Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Extranodal NK-T-cell lymphoma history and symptoms

Introduction

Overview

Overview

The most common symptoms of extranodal NK-T-cell lymphoma include fever, weight loss, skin rash, night sweats, protrusion of eye, swelling of the face, discharge from the nose, nose bleeds, blockage of the nasal passages, chest pain, abdominal pain, bone pain, and painless swelling in the neck, axilla, groin, thorax, and abdomen. Extranodal NK/T cell lymphoma, nasal type, which is the most common sub type, is usually found as an ulcerative and necrotic granuloma in the nasal cavity, palate, and nasopharynx. Tumor can spread to surrounding tissue such as facial skin, paranasal sinus, and orbits, and cause exensive destruction of midline lesions. The most common symptoms at the time of diagnosis are nasal obstruction and bloody rhinorea.

Symptoms

Symptoms

  • Extranodal NK/T cell lymphoma, nasal type, which is the most common subtype, is usually found as an ulcerative and necrotic granuloma in the nasal cavity, palate, and nasopharynx.[5] [6]
  • Tumor can spread to surrounding tissue such as facial skin, paranasal sinus, and orbits, and cause extensive destruction of midline lesions.
  • The most common symptoms at the time of diagnosis are nasal obstruction and bloody rhinorrhea.[7]
References

References

  1. ↑ Extranodal NK-/T-cell lymphoma, nasal type. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd530f/. Accessed on February 02, 2016
  2. ↑ Extranodal NK/T-cell lymphoma, nasal type. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/extranodal-nk-t-cell-lymphoma-nasal-type/?region=on. Accessed on February 04, 2016
  3. ↑ Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016
  4. ↑ Wu, X.; Li, P.; Zhao, J.; Yang, X.; Wang, F.; Yang, Y.Q.; Fang, F.; Xu, Y.; Zhang, H.; Wang, W.Y.; Yi, C. (2008). “A Clinical Study of 115 Patients with Extranodal Natural Killer/T-cell Lymphoma, Nasal Type”. Clinical Oncology. 20 (8): 619–625. doi:10.1016/j.clon.2008.05.011. ISSN 0936-6555.
  5. ↑ Harabuchi, Yasuaki; Kataura, Akikatsu; Kobayashi, Kazutoyo; Yamamoto, Tetsuo; Yamanaka, Noboru; Hirao, Motoyasu; Onodera, Kazufumi; Kon, Shinichiro (1992). “Lethal midline granuloma (peripheral T-cell lymphoma) after lymphomatoid papulosis”. Cancer. 70 (4): 835–839. doi:10.1002/1097-0142(19920815)70:4<835::AID-CNCR2820700419>3.0.CO;2-F. ISSN 0008-543X.
  6. ↑ Harabuchi, Y.; Yamanaka, N.; Kataura, A.; Imai, S.; Kinoshita, T.; Osato, T. (1990). “Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma”. The Lancet. 335 (8682): 128–130. doi:10.1016/0140-6736(90)90002-M. ISSN 0140-6736.
  7. ↑ Wu, X.; Li, P.; Zhao, J.; Yang, X.; Wang, F.; Yang, Y.Q.; Fang, F.; Xu, Y.; Zhang, H.; Wang, W.Y.; Yi, C. (2008). “A Clinical Study of 115 Patients with Extranodal Natural Killer/T-cell Lymphoma, Nasal Type”. Clinical Oncology. 20 (8): 619–625. doi:10.1016/j.clon.2008.05.011. ISSN 0936-6555.


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: , Ramyar Ghandriz MD[2] Sowminya Arikapudi, M.B,B.S. [3]